Skip to content

Novanta NOVT Other intangible assets—net

Other intangible assets—net at other companies

Stryker logo
StrykerSYK
$5.52B-10.0%
Belden logo
BeldenBDC
$392.43M-5.8%
Intuitive Surgical logo
Intuitive SurgicalISRG
Onto Innovation logo
Onto InnovationONTO
Globus Medical logo
Globus MedicalGMED
Regal Rexnord logo
Regal RexnordRRX

Other financials

Income statement

See full
Revenue$257.7M+10.4%
Gross profit$113.6M+8.8%
Operating income$27.5M-15.1%
Net income$21.1M-0.5%
EPS (diluted)$0.51-13.6%

Balance sheet

See full
Cash & equivalents$388.8M+267%
Total debt$291.3M-34.2%
Total equity$1.3B+70.3%
Total assets$1.8B+29.9%

Cash flow

See full
Operating cash flow$51.6M+62.9%
CapEx$4.1M-3.4%
Free cash flow$47.5M+73.2%

Valuation

See full
Market cap$5.53B-8.3%

Profitability

See full
Gross margin44.2%-0.5pp
Operating margin8.9%-3.5pp
Net margin5.3%-2.1pp
FCF margin6.8%-8.1pp

Returns & leverage

See full
Return on equity5.2%-4.6pp
Debt / equity0.2×-0.4×
Current ratio3.6×+1.0×

Where this comes from

Reported directly by Novanta in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The official record: Novanta’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novanta's other intangible assets—net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novanta's other intangible assets—net?
Novanta (NOVT) reported other intangible assets—net of $170.3M in Q1 2026.
How has Novanta's other intangible assets—net changed year-over-year?
Novanta's other intangible assets—net decreased by 4.2% year-over-year, from $177.72M to $170.3M.
What is the long-term trend for Novanta's other intangible assets—net?
Over 5 years (2020 to 2025), Novanta's other intangible assets—net has grown at a 4.0% compound annual growth rate (CAGR), from $148.52M to $180.78M.
What does other intangible assets—net mean?
This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.